[ad_1]
The Netherlands temporarily suspends corona vaccines with the manufacturer’s Astrazeneca vaccine, for two weeks. It is following the example of Denmark, Norway, Iceland, Bulgaria and Ireland, which at the moment no longer administer the vaccine from the British-Swedish manufacturer due to indications of possible side effects.
The Medicines Agency recommended this “precautionary measure” based on new information. More tests will now be carried out, the Dutch Health Ministry said Sunday night. “The crucial question is whether the complaints arose after or due to vaccination,” said Health Minister Hugo de Jonge. So far, there is no known case in the Netherlands in which serious side effects have occurred.
Denmark suspended vaccines with the drug Astrazeneca for the first time on Thursday. The Danish Health Authority referred to reports of serious blood clots in vaccinated people; one person died of a blood clot shortly after being vaccinated. It has not yet been conclusively clarified whether there is a connection. Since then, Norway, Iceland, Bulgaria and, more recently, Ireland have announced the suspension of vaccines with Astrazeneca.
In Norway, three youths developed blood clots or brain hemorrhage in three youths after vaccination and, in several cases, vaccinated youths are said to have developed hemorrhages or bruises.
In the northern Italian city of Biella, a teacher died after administering Astrazeneca. The Piedmont region temporarily suspended vaccines on Sunday, in the evening they continued with other batches (it had received one from batch ABV5811). On Friday, the Aifa drug agency stopped managing a batch of Astrazeneca after two soldiers and a police officer were killed in Sicily. Three more deaths are being determined, including the death of a deputy director in Bologna.
In Austria, a 49-year-old nurse from the Zwettl State Hospital died as a result of severe bleeding disorders, a 35-year-old colleague developed a pulmonary embolism, but recently recovered. In these two cases in Lower Austria, the women in question had previously received vaccines from the same batch of the Astrazeneca vaccine.
The European Medicines Agency (EMA) had stated that there was no appreciable accumulation of thrombosis in connection with vaccination.
